Table 3 Point assignment from nomograms and prognostic score.
From: Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma
Characteristics | Primary cohort (No of patients) | validation cohort (No of patients) | score | 5-year OS |
|---|---|---|---|---|
NLR | ||||
≥2.73 | 109 | 35 | 69 | 75% |
<2.73 | 256 | 87 | 0 | 85% |
LDH | ||||
≥245 | 34 | 12 | 70 | 67% |
<245 | 331 | 110 | 0 | 84% |
Age | ||||
≥50years | 164 | 59 | 89 | 74% |
<50years | 201 | 63 | 0 | 89% |
Tstage | ||||
T1-2 | 96 | 23 | 0 | 88% |
T3-4 | 269 | 99 | 97 | 80% |
Nstage | ||||
N0-1 | 84 | 28 | 0 | 85% |
N2-3 | 281 | 94 | 100 | 81% |
OSstatus | ||||
live | 301 | 100 | ||
dead | 64 | 22 | ||
Risk groups | ||||
Low risk | 81 | 19 | <216 | 96% |
Intermediate risk | 250 | 84 | 216–306 | 81% |
High risk | 34 | 19 | ≥306 | 60% |
